Victor Frenkel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Victor Frenkel has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- King C. P. Li
Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America
8 shared publications - Bradford J. Wood
Center for Interventional Oncology, NCI, NIH, Bethesda, MD, USA
6 shared publications - David S. Hersh
Department of Neurosurgery, UConn School of Medicine, Farmington
6 shared publications - Ali Mohammadabadi
HEPIUS Innovation Laboratory, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
4 shared publications Mary Angstadt
Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA 20892
4 shared publicationsSergio Dromi
Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
4 shared publications
Latest Publications
- Open Access
- 17 June 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications
Stem cell and immune cell therapies are being investigated as a potential therapeutic modality for CNS disorders, performing functions such as targeted drug or growth factor delivery, tumor cell destruction, or inflammatory regulation. Despite promising preclinical studies, delivery routes for maximizing cell engraftment, such as stereotactic or intrathecal injection, are invasive and carry risks of hemorrhage and infection. Recent developments in MRI-guided focused ultrasound (MRgFUS) technology have significant implications for treating focal CNS pathologies including neurodegenerative, vascular and malignant processes. MRgFUS is currently employed in the clinic for treating essential tremor and Parkinson's Disease by producing precise, incisionless, transcranial lesions. This non-invasive technology can also be modified for non-destructive applications to safely and transiently open the blood-brain barrier (BBB) to deliver a range of therapeutics, including cells. This review is meant to familiarize the neuro-interventionalist with this topic and discusses the use of MRgFUS for facilitating cellular delivery to the brain. A detailed and comprehensive description is provided on routes of cell administration, imaging strategies for targeting and tracking cellular delivery and engraftment, biophysical mechanisms of BBB enhanced permeability, supportive proof-of-concept studies, and potential for clinical translation.
- 17 June 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Open AccessMRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications
Stem cell and immune cell therapies are being investigated as a potential therapeutic modality for CNS disorders, performing functions such as targeted drug or growth factor delivery, tumor cell destruction, or inflammatory regulation. Despite promising preclinical studies, delivery routes for maximizing cell engraftment, such as stereotactic or intrathecal injection, are invasive and carry risks of hemorrhage and infection. Recent developments in MRI-guided focused ultrasound (MRgFUS) technology have significant implications for treating focal CNS pathologies including neurodegenerative, vascular and malignant processes. MRgFUS is currently employed in the clinic for treating essential tremor and Parkinson's Disease by producing precise, incisionless, transcranial lesions. This non-invasive technology can also be modified for non-destructive applications to safely and transiently open the blood-brain barrier (BBB) to deliver a range of therapeutics, including cells. This review is meant to familiarize the neuro-interventionalist with this topic and discusses the use of MRgFUS for facilitating cellular delivery to the brain. A detailed and comprehensive description is provided on routes of cell administration, imaging strategies for targeting and tracking cellular delivery and engraftment, biophysical mechanisms of BBB enhanced permeability, supportive proof-of-concept studies, and potential for clinical translation.
- 21 December 2020
- Published by Wiley in MEDICAL DEVICES & SENSORS
- Vol. 4 (1)
Beam characterization of a custom, handheld focused ultrasound system using thermochromic liquid crystal films
Focused Ultrasound (FUS) continues to gain acceptance in the clinical realm for its ability to provide effective, non‐invasive therapeutic treatments to almost any region of the body for a host of ablative and non‐ablative applications. The development of FUS devices and their implementation requires reliable characterization and quality assurance methods to verify acoustic pressure fields and focal region characteristics. The use of hydrophones is a conventional technique for mapping the acoustic field in 3 dimensions to provide focal dimensions and location. Hydrophones, however, are expensive and may be damaged even at relatively low acoustic amplitudes. Data collection with these devices can also be labor intensive and difficult to accurately reproduce. We present preliminary findings for the development of an alternative characterization process for FUS transducers that is relatively inexpensive and time efficient. Thermochromic liquid crystal (TLC) film sensors exploit the thermochromic effect, in which exposure to specific temperature changes cause a visible change in colour. The method was tested on a portable FUS system developed in‐house for FUS‐based therapeutic applications, comprised of a 3.57 MHz FUS transducer, and a custom‐fabricated coupling cone. The results demonstrated that this method using TLC films was able to accurately provide dimensions of the focal zone and its position relative to the transducer hardware. Numerical simulations were performed along with acoustic hydrophone measurements to corroborate this data, which were found to be in general agreement. With future refinements, this cost‐effective method could be practical as an expedient and cost‐effective characterization technique for in‐house FUS transducer development.
- 21 December 2020
- Published by Wiley in MEDICAL DEVICES & SENSORS
- Vol. 4 (1)
Beam characterization of a custom, handheld focused ultrasound system using thermochromic liquid crystal films
Focused Ultrasound (FUS) continues to gain acceptance in the clinical realm for its ability to provide effective, non‐invasive therapeutic treatments to almost any region of the body for a host of ablative and non‐ablative applications. The development of FUS devices and their implementation requires reliable characterization and quality assurance methods to verify acoustic pressure fields and focal region characteristics. The use of hydrophones is a conventional technique for mapping the acoustic field in 3 dimensions to provide focal dimensions and location. Hydrophones, however, are expensive and may be damaged even at relatively low acoustic amplitudes. Data collection with these devices can also be labor intensive and difficult to accurately reproduce. We present preliminary findings for the development of an alternative characterization process for FUS transducers that is relatively inexpensive and time efficient. Thermochromic liquid crystal (TLC) film sensors exploit the thermochromic effect, in which exposure to specific temperature changes cause a visible change in colour. The method was tested on a portable FUS system developed in‐house for FUS‐based therapeutic applications, comprised of a 3.57 MHz FUS transducer, and a custom‐fabricated coupling cone. The results demonstrated that this method using TLC films was able to accurately provide dimensions of the focal zone and its position relative to the transducer hardware. Numerical simulations were performed along with acoustic hydrophone measurements to corroborate this data, which were found to be in general agreement. With future refinements, this cost‐effective method could be practical as an expedient and cost‐effective characterization technique for in‐house FUS transducer development.
- 22 June 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (12) , 125017
Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors
Nanocarriers offer a promising approach to significantly improve therapeutic delivery to solid tumors as well as limit the side effects associated with anti-cancer agents. However, their relatively large size can negatively affect their ability to efficiently penetrate into more interior tumor regions, ultimately reducing therapeutic efficacy. Poor penetration of large agents such as nanocarriers is attributed to factors in the tumor microenvironment such as elevated interstitial fluid pressure (IFP) and fibrillar collagen in the extracellular matrix. Our previous studies reported that pretreatment of solid tumor xenografts with nondestructive pulsed focused ultrasound (pFUS) can improve the delivery and subsequent therapy of a variety of therapeutic formulations in different tumor models, where the results were associated with expanded extracellular spaces (ECS), an increase in hydraulic conductivity, and decrease in tissue stiffness. Here, we demonstrate the inverse relationship between IFP and the penetration of systemically administered nanoparticle (NP) probes, where IFP increased from the tumor periphery to their center. Furthermore, we show that pretreatment with pFUS can safely reduce IFP and improve NP delivery; especially into the center of the tumors. These results coincide with effects generated in the fibrillar collagen network microstructure in the ECS as determined by quantitative polarized light microscopy. Whole tumor and histomorphometric analysis, however, did not show significant differences in collagen area fraction or collagen feature solidity, as well as tumor cross-sectional area and aspect ratio, as a result of the treatments. We present a biophysical model connecting the experimental results, where pFUS-mediated cytoarchitectural changes are associated with improved redistribution of the interstitial fluid and lower IFP. The resulting improvement in NP delivery supports our previous therapeutic studies and may have implications for clinical applications to improve therapeutic outcomes in cancer therapy.
- 22 June 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (12) , 125017
Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors
Nanocarriers offer a promising approach to significantly improve therapeutic delivery to solid tumors as well as limit the side effects associated with anti-cancer agents. However, their relatively large size can negatively affect their ability to efficiently penetrate into more interior tumor regions, ultimately reducing therapeutic efficacy. Poor penetration of large agents such as nanocarriers is attributed to factors in the tumor microenvironment such as elevated interstitial fluid pressure (IFP) and fibrillar collagen in the extracellular matrix. Our previous studies reported that pretreatment of solid tumor xenografts with nondestructive pulsed focused ultrasound (pFUS) can improve the delivery and subsequent therapy of a variety of therapeutic formulations in different tumor models, where the results were associated with expanded extracellular spaces (ECS), an increase in hydraulic conductivity, and decrease in tissue stiffness. Here, we demonstrate the inverse relationship between IFP and the penetration of systemically administered nanoparticle (NP) probes, where IFP increased from the tumor periphery to their center. Furthermore, we show that pretreatment with pFUS can safely reduce IFP and improve NP delivery; especially into the center of the tumors. These results coincide with effects generated in the fibrillar collagen network microstructure in the ECS as determined by quantitative polarized light microscopy. Whole tumor and histomorphometric analysis, however, did not show significant differences in collagen area fraction or collagen feature solidity, as well as tumor cross-sectional area and aspect ratio, as a result of the treatments. We present a biophysical model connecting the experimental results, where pFUS-mediated cytoarchitectural changes are associated with improved redistribution of the interstitial fluid and lower IFP. The resulting improvement in NP delivery supports our previous therapeutic studies and may have implications for clinical applications to improve therapeutic outcomes in cancer therapy.
- Open Access
- 28 March 2019
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 18 (1) , 36
Design, characterization and evaluation of a laser-guided focused ultrasound system for preclinical investigations
The clinical applications of transcranial focused ultrasound continue to expand and include ablation as well as drug delivery applications in the brain, where treatments are typically guided by MRI. Although MRI-guided focused ultrasound systems are also preferred for many preclinical investigations, they are expensive to purchase and operate, and require the presence of a nearby imaging center. For many basic mechanistic studies, however, MRI is not required. The purpose of this study was to design, construct, characterize and evaluate a portable, custom, laser-guided focused ultrasound system for noninvasive, transcranial treatments in small rodents. The system comprised an off-the-shelf focused ultrasound transducer and amplifier, with a custom cone fabricated for direct coupling of the transducer to the head region. A laser-guidance apparatus was constructed with a 3D stage for accurate positioning to 1 mm. Pressure field simulations were performed to demonstrate the effects of the coupling cone and the sealing membrane, as well as for determining the location of the focus and acoustic transmission across rat skulls over a range of sizes. Hydrophone measurements and exposures in hydrogels were used to assess the accuracy of the simulations. In vivo treatments were performed in rodents for opening the blood–brain barrier and to assess the performance and accuracy of the system. The effects of varying the acoustic pressure, microbubble dose and animal size were evaluated in terms of efficacy and safety of the treatments. The simulation results were validated by the hydrophone measurements and exposures in the hydrogels. The in vivo treatments demonstrated the ability of the system to open the blood–brain barrier. A higher acoustic pressure was required in larger-sized animals, as predicted by the simulations and transmission measurements. In a particular sized animal, the degree of blood–brain barrier opening, and the safety of the treatments were directly associated with the microbubble dose. The focused ultrasound system that was developed was found to be a cost-effective alternative to MRI-guided systems as an investigational device that is capable of accurately providing noninvasive, transcranial treatments in rodents.
- 28 March 2019
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 18 (1) , 36
Open AccessDesign, characterization and evaluation of a laser-guided focused ultrasound system for preclinical investigations
The clinical applications of transcranial focused ultrasound continue to expand and include ablation as well as drug delivery applications in the brain, where treatments are typically guided by MRI. Although MRI-guided focused ultrasound systems are also preferred for many preclinical investigations, they are expensive to purchase and operate, and require the presence of a nearby imaging center. For many basic mechanistic studies, however, MRI is not required. The purpose of this study was to design, construct, characterize and evaluate a portable, custom, laser-guided focused ultrasound system for noninvasive, transcranial treatments in small rodents. The system comprised an off-the-shelf focused ultrasound transducer and amplifier, with a custom cone fabricated for direct coupling of the transducer to the head region. A laser-guidance apparatus was constructed with a 3D stage for accurate positioning to 1 mm. Pressure field simulations were performed to demonstrate the effects of the coupling cone and the sealing membrane, as well as for determining the location of the focus and acoustic transmission across rat skulls over a range of sizes. Hydrophone measurements and exposures in hydrogels were used to assess the accuracy of the simulations. In vivo treatments were performed in rodents for opening the blood–brain barrier and to assess the performance and accuracy of the system. The effects of varying the acoustic pressure, microbubble dose and animal size were evaluated in terms of efficacy and safety of the treatments. The simulation results were validated by the hydrophone measurements and exposures in the hydrogels. The in vivo treatments demonstrated the ability of the system to open the blood–brain barrier. A higher acoustic pressure was required in larger-sized animals, as predicted by the simulations and transmission measurements. In a particular sized animal, the degree of blood–brain barrier opening, and the safety of the treatments were directly associated with the microbubble dose. The focused ultrasound system that was developed was found to be a cost-effective alternative to MRI-guided systems as an investigational device that is capable of accurately providing noninvasive, transcranial treatments in rodents.
- Open Access
- 7 February 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (2) , e0192240
MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain
Generating spatially controlled, non-destructive changes in the interstitial spaces of the brain has a host of potential clinical applications, including enhancing the delivery of therapeutics, modulating biological features within the tissue microenvironment, altering fluid and pressure dynamics, and increasing the clearance of toxins, such as plaques found in Alzheimer’s disease. Recently we demonstrated that ultrasound can non-destructively enlarge the interstitial spaces of the brain ex vivo. The goal of the current study was to determine whether these effects could be reproduced in the living brain using non-invasive, transcranial MRI-guided focused ultrasound (MRgFUS). The left striatum of healthy rats was treated using MRgFUS. Computer simulations facilitated treatment planning, and targeting was validated using MRI acoustic radiation force impulse imaging. Following MRgFUS treatments, Evans blue dye or nanoparticle probes were infused to assess changes in the interstitial space. In MRgFUS-treated animals, enhanced dispersion was observed compared to controls for 70 nm (12.8 ± 0.9 mm3 vs. 10.6 ± 1.0 mm3, p = 0.01), 200 nm (10.9 ± 1.4 mm3 vs. 7.4 ± 0.7 mm3, p = 0.01) and 700 nm (7.5 ± 0.4 mm3 vs. 5.4 ± 1.2 mm3, p = 0.02) nanoparticles, indicating enlargement of the interstitial spaces. No evidence of significant histological or electrophysiological injury was identified. These findings suggest that transcranial ultrasound can safely and effectively modulate the brain interstitium and increase the dispersion of large therapeutic entities such as particulate drug carriers or modified viruses. This has the potential to expand the therapeutic uses of MRgFUS.
- 7 February 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (2) , e0192240
Open AccessMR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain
Generating spatially controlled, non-destructive changes in the interstitial spaces of the brain has a host of potential clinical applications, including enhancing the delivery of therapeutics, modulating biological features within the tissue microenvironment, altering fluid and pressure dynamics, and increasing the clearance of toxins, such as plaques found in Alzheimer’s disease. Recently we demonstrated that ultrasound can non-destructively enlarge the interstitial spaces of the brain ex vivo. The goal of the current study was to determine whether these effects could be reproduced in the living brain using non-invasive, transcranial MRI-guided focused ultrasound (MRgFUS). The left striatum of healthy rats was treated using MRgFUS. Computer simulations facilitated treatment planning, and targeting was validated using MRI acoustic radiation force impulse imaging. Following MRgFUS treatments, Evans blue dye or nanoparticle probes were infused to assess changes in the interstitial space. In MRgFUS-treated animals, enhanced dispersion was observed compared to controls for 70 nm (12.8 ± 0.9 mm3 vs. 10.6 ± 1.0 mm3, p = 0.01), 200 nm (10.9 ± 1.4 mm3 vs. 7.4 ± 0.7 mm3, p = 0.01) and 700 nm (7.5 ± 0.4 mm3 vs. 5.4 ± 1.2 mm3, p = 0.02) nanoparticles, indicating enlargement of the interstitial spaces. No evidence of significant histological or electrophysiological injury was identified. These findings suggest that transcranial ultrasound can safely and effectively modulate the brain interstitium and increase the dispersion of large therapeutic entities such as particulate drug carriers or modified viruses. This has the potential to expand the therapeutic uses of MRgFUS.
- 1 September 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Notice of Removal: Pulsed focused ultrasound effects on the brain interstitium
Removed.
- 1 September 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Notice of Removal: Pulsed focused ultrasound effects on the brain interstitium
Removed.
- 1 May 2017
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 141 (5_Suppleme) , 3460
Focus ultrasound for augmenting convection-enhanced delivery of nanoparticles in the brain
We previously demonstrated how ultrasound can enhance the dispersion of locally administrated nanoparticles within the extracellular/perivascular spaces in the ex vivo brain by non-destructively enlarging these regions. The current study aimed to translate these results in vivo , where custom, non-adhering brain-penetrating nanoparticles (BPN: 60, 200, and 500 nm), were administered directly into the brains of Sprague Dawley rats by convection-enhanced delivery. Non-invasive, transcranial focused ultrasound (TCFUS) was carried out using an MRI-guided system (1.5 MHz, 10 ms pulses, 10% duty cycle, and 2.3 MPa). 15 individual exposures in a 3 × 5 matrix (spacing: 1.5 mm) in one hemisphere were given, where the size of the focal zone (-6 dB) was 1 × 1 X 8 mm. At 2hrs post-treatment brains were harvested and sectioned, with digital images captured and processed using a custom MATLAB script. This involved the “Otsu” thresholding method, based on gray level histograms and threshold determinations for maximizing the interclass variance. As expected, BPN distributions in the non-treated brains decreased with an increase in diameter. Pretreating with TCFUS was found to significantly increase the distribution of the 200 nm BPNs. These results have broad implications for therapeutic delivery for a variety of brain diseases and disorders.
- 1 May 2017
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 141 (5_Suppleme) , 3460
Focus ultrasound for augmenting convection-enhanced delivery of nanoparticles in the brain
We previously demonstrated how ultrasound can enhance the dispersion of locally administrated nanoparticles within the extracellular/perivascular spaces in the ex vivo brain by non-destructively enlarging these regions. The current study aimed to translate these results in vivo , where custom, non-adhering brain-penetrating nanoparticles (BPN: 60, 200, and 500 nm), were administered directly into the brains of Sprague Dawley rats by convection-enhanced delivery. Non-invasive, transcranial focused ultrasound (TCFUS) was carried out using an MRI-guided system (1.5 MHz, 10 ms pulses, 10% duty cycle, and 2.3 MPa). 15 individual exposures in a 3 × 5 matrix (spacing: 1.5 mm) in one hemisphere were given, where the size of the focal zone (-6 dB) was 1 × 1 X 8 mm. At 2hrs post-treatment brains were harvested and sectioned, with digital images captured and processed using a custom MATLAB script. This involved the “Otsu” thresholding method, based on gray level histograms and threshold determinations for maximizing the interclass variance. As expected, BPN distributions in the non-treated brains decreased with an increase in diameter. Pretreating with TCFUS was found to significantly increase the distribution of the 200 nm BPNs. These results have broad implications for therapeutic delivery for a variety of brain diseases and disorders.
- 1 January 2017
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 70, 461-470
Development of a custom biological scaffold for investigating ultrasound-mediated intracellular delivery
- 1 January 2017
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 70, 461-470
Development of a custom biological scaffold for investigating ultrasound-mediated intracellular delivery
- 1 November 2016
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 79 (5) , 643-654
Emerging Applications of Therapeutic Ultrasound in Neuro-oncology
Transcranial focused ultrasound (FUS) can noninvasively transmit acoustic energy with a high degree of accuracy and safety to targets and regions wit
- 1 November 2016
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 79 (5) , 643-654
Emerging Applications of Therapeutic Ultrasound in Neuro-oncology
Transcranial focused ultrasound (FUS) can noninvasively transmit acoustic energy with a high degree of accuracy and safety to targets and regions wit
- 1 September 2016
- Published by Elsevier in Brain Research
- Vol. 1646, 543-550
Pulsed ultrasound expands the extracellular and perivascular spaces of the brain
- 1 September 2016
- Published by Elsevier in Brain Research
- Vol. 1646, 543-550
Pulsed ultrasound expands the extracellular and perivascular spaces of the brain